Form 8-K INCYTE CORP For: Jun 22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/1/2026
- Wall Street ends choppy session lower as tech shares drop
- Meta Platforms stock surges 8% on cloud business plans
- Humanoid robot component stocks surge on supply-chain optimism
- Oil prices fall 1% to 4-month lows as progress in US-Iran talks cools supply concerns
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- Cantor Fitzgerald Starts Forward Industries (FWDI) at Overweight
- DISH DBS files prepackaged chapter 11 to repay debt, wind down wireless
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Taiwan prosecutors detain Super Micro employees over chip exports
Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
June 22, 2026 7:53 AM EDTIncyte Corporation (NASDAQ: INCY) has reached a settlement with the Centers for Medicare & Medicaid Services (CMS) over a dispute regarding Medicaid rebate rules applied to its drug Opzelura (ruxolitinib) cream, according to a company statement.
Under the agreement, CMS will not classify... More
